Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy
NCT00530569
·
clinicaltrials.gov ↗
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
PROCEDURE:
Blood Test
Sponsor
Alberta Health services